Maybe they will post the shareholder meeting slides as they
Maybe they will post the shareholder meeting slides as they have done in the past.
Not sure on these three:
1) TNBC ODD: With TNBC ODD, I know there has been some confusion. But the last I remember is NP saying there applied maybe 60-70 days ago and will be checking on it.
Since they are after MOA in many cancers, and there is preclinical data with ccr5 inhibitors with many cancers, I wonder if the FDA will deny ODD for TNBC because the potential market size is much bigger than 200k or if they will stick with just TNBC and say yes.
2) Animal Preclinical Trials Preliminary Data -- I have not seen an update if they have started. I believe NP said in the CC that Colon IND for Phase 2 is not based on this data, but previous data. So maybe they haven't started, as you would think that would be the first one.
3) Monotherapy: IncellDx Dose/CCR5 Analysis Results. I not remember hearing anything new.
So maybe (if we don't get a pr this week), just to get discussion for June milestones started.
June
TNBC Phase 2 Trial: First Three Patients Injected at 350mg (stage 1 of 3+3)
Mono pivotal phase 3 trial FDA's response
Initiate mono pivotal phase 3 (on their list of milestones for June, but maybe July)
TO closes
FDA response to allow 525mg safety data with Combo
BLA Part 2 possible (with FDA approval of 525mg) June-July
Colon Cancer Phase 2 Trial IND Submission
Results from NASH mice study (possible but not certain)
Convertible note paid A BIG ONE (alps is dropping shares again this morning)
ASM Microbe 2019 June 21st
Prostate Cancer Test 510(k) filing
1
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Unpacking the Texas Auto Insurance Puzzle Ah, Texas. Land of vast highways and, apparently, some rather eyebrow-raising auto insurance complexities. Teri Cappadona from the Sapp Insurance Agency took to HelloNation to lay down the lowdown. If you're not up to speed, you might be blindsiding your bank account. We've all grumbled at those insurance bills, but understanding...
Continue Reading
Picking Apart Furniture Quality Before a Purchase In a world where cheap and flashy often overshadow durability, knowing what makes furniture stand the test of time isn't just wise—it's essential. Learn from Nate Bartlett, the furniture sage from Charlevoix, Michigan, who guides shoppers through the maze of quality indicators in a recent HelloNation article. If you're...
Continue Reading
A Crippling Blow for ServiceTitan Investors When you're in the investing game long enough, you start to recognize the scent of trouble before it even hits the fan. In the case of ServiceTitan, Inc. (NASDAQ: TTAN), the smell came wafting in strong when the stock took a nosedive on September 9, 2026. Investors were left clutching their portfolios with bewilderment as shares...
Continue Reading
Neuberger Boosts Distribution: What's Driving This? I ain't about to sugarcoat it: the Neuberger Next Generation Connectivity Fund (NYSE: NBXG) decided to jack up its monthly distribution rate to $0.132 per share. This announcement, hitting wallets on November 30, 2026, has a record and ex-date of November 16. Now, that's a good ol' reliable payout for folks holding NBXG...
Continue Reading
New Chapter for Bel-Mac and Seashore In a move that's got the local construction scene buzzing, Bel-Mac Roofing and Seashore Construction are tying the knot. It's more than just a merger; it's a power play to dominate Northwest Florida and the Gulf Coast with roofing and exterior construction services. The strategic investment from ACACIA Exterior Building Group sets the...
Continue Reading
Vet the Process Before Diving In Everyone wants to turn back the clock on their skin, but it's crucial to know what you're getting into. This ain't a quick splash of water on the face; it's radiofrequency microneedling we're talking about. And honey, it’s no fairy tale—it’s science, plain and simple. Drilling Down on Microneedling This procedure, preached by Dr....
Continue Reading
Talk about a match made for the tech-savvy folks who just can't wait to shatter the confines of the usual cloud service monopoly. In comes LakeSail, locking arms with Oxide Computer Company to offer something quite tantalizing: a chance for enterprises to handle AI workloads with the iron-fisted control they crave nowadays. Yeah, we're talking customer-owned...
Continue Reading
When Promises Fall Short for Investors Look, the market's a tough beast, and Lincoln Educational Services (NASDAQ:LINC) just got stomped by it. From May through early August 2026, investors felt cozy with Lincoln's rosy pronouncements. Then, come August 10, Lincoln drops a dud: an abysmal 1% growth in student starts, tanking their share price by nearly a quarter. Yeah,...
Continue Reading
Credentials in the Spotlight at PESC Summit When you're talking credentials and data standards at the PESC Summit, you've got a gathering of big brains aiming to steer the wild ride of higher education into the future. This October, University of Phoenix leaders stepped up to the plate in Scottsdale, Arizona, delivering a frank talk about the role of credentials in...
Continue Reading
Barry Sonnenfeld Takes Center Stage The spotlight is set for a different kind of blockbuster event—not on the silver screen this time, but under the starlit glamour of Beverly Hills. That's right, folks, Barry Sonnenfeld, the DGA and Emmy award-laden filmmaker we all know and love, will be the maestro hosting the Children's Institute's (CII) Cape & Gown Gala on November...
Continue Reading
Top 5 Most Recently Viewed Articles
Rethink Wildlife Tourism for Ethical Travel You ever stopped to think about what those so-called wildlife attractions are really selling? It’s a feel-good illusion wrapped up in exploitation. Travelers often see animals as part of the backdrop of their holiday stories, but the reality is far from picturesque. Behind the photo ops, there's typically a grim story of...
Continue Reading
Understanding Take-Two Interactive's Long-Term Growth Take-Two Interactive (NASDAQ: TTWO) has delivered impressive returns to its investors over the last twenty years, significantly outpacing the general market. With an annualized return of 13.62%, this entertainment giant has showcased the power of smart investment choices. What Happens When You Invest in TTWO? Imagine...
Continue Reading
Understanding the Opportunity for Allarity Investors Investors in Allarity Therapeutics, Inc. (NASDAQ: ALLR) have been alerted to a significant opportunity. A class action lawsuit is in progress concerning securities fraud, and those who purchased shares within a specified timeframe may be eligible for compensation. Details of the Class Period The class period runs from...
Continue Reading
High-Grade Results from NexGold Mining Corp. Toronto, December 5, 2024 – NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) is thrilled to announce remarkable results from the C Zone East, showcasing substantial intersections of high-grade gold. This recent exploration at the Goliath Gold Complex has revealed substantial gold mineralization below the current mineral...
Continue Reading
David P. Joyce Engages in MAI Managed Income Fund Transaction Recent reports have come to light regarding the investment activities of David P. Joyce, a notable figure representing Ohio's 14th congressional district. It has been disclosed that he performed a partial sale of his stake in the MAI Managed Income Fund (HN). The details of this transaction were documented in a...
Continue Reading